logo
Plus   Neg
Share
Email

Bayer, Daré Bioscience Sign License Agreement On Ovaprene

Bayer and Daré Bioscience Inc. (DARE) entered into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene.

In Monday regular trade, DARE is trading at $2.00, up $1.16 or 139.52 percent.

Bayer may commercialize Daré's investigational contraceptive product, Ovaprene in the United States once approved by the FDA.

The licensing option becomes effective with a payment of $20 million from Bayer to Daré.

Daré might be eligible to receive commercial milestone payments potentially totaling $310 million as well as double-digit tiered royalties on net sales.

As per the deal, Daré will receive an upfront payment and access to Bayer's clinical and market capabilities while retaining control over Ovaprene's development and regulatory approval process.

Daré plans to file an Investigational Device Exemption for Ovaprene in the first half of 2020 and to initiate a pivotal contraceptive effectiveness and safety clinical study of Ovaprene in the second half of 2020.

If successful, Daré expects that study to support marketing approvals of Ovaprene in the U.S., Europe and other countries worldwide.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Casino operator MGM Resorts International said it was the victim of a data breach in 2019 after a report claimed that the details of more than 10.6 million hotel guests were exposed. Technology website ZDNet reported about the incident late on Wednesday, saying that the personal details of more than 10.6 guests who stayed at MGM Resorts hotels were published on a hacking forum this week. Amid the ongoing troubles with its 737 MAX commercial planes grounding since March 2019, Boeing (BA) has secured a five-year U.S. Air Force contract to sustain and modernize the Global Decision Support System, or GDSS. The financial terms of the deal were not disclosed. The contract was awarded to Tapestry Solutions, part of Boeing Global Services. Reinsurer Swiss Re reported Thursday significantly higher profit in fiscal 2019 driven by higher premiums mainly in property and casualty businesses, despite heavy natural catastrophe losses. The company also said it will propose higher dividend and share buyback of up to 1 billion Swiss Francs. Swiss Re were losing around 4 percent in trading.
Follow RTT
>